Ossur Hf : Share options granted

Announcement from Össur hf. No.20/2012
Reykjavik, 23 May 2012

Today,  Össur hf. has granted 500,000 share options to Dr. Thorvaldur Ingvarsson
who will become Executive Vice President of R&D at Össur as of 30 June 2012. The
exercise price is DKK 8.59, i.e. the Company's average share price on NASDAQ OMX
Copenhagen  20 trading days prior to the grant  date. First exercise date is 23
May 2015. Dr. Ingvarsson holds no shares in Össur.

The  share options  are granted  in accordance  with the  Company's share option
scheme implemented on 24 April 2012. Further details on the share option scheme,
including  the  key  terms  and  conditions,  can  be  found  in  the  Company's
announcement No. 16/2012 published on 24 April 2012.

Össur press releases by e-mail

If  you wish to  receive Össur press  releases by e-mail  please register at the
following web-site: http://www.ossur.com/investormailings.



About Össur
Össur (NASDAQ OMX: OSSR) is a global leader in non-invasive orthopaedics that
help people live a life without limitations. Its business is focused on
improving people's mobility through the delivery of innovative technologies
within the fields of braces, supports, prosthetic limbs and compression therapy,
including the Flex-Foot Cheetah carbon fiber running prostheses used by "The
Blade Runner," renowned double-amputee sprinter Oscar Pistorius. A recognized
"Technology Pioneer", Össur invests significantly in research and product
development; its award-winning designs ensuring a consistently strong position
in the market. Successful patient and clinical outcomes are further empowered
via Össur's educational programs and business solutions. Headquartered in
Iceland, Össur has major operations in the Americas, Europe and Asia, with
additional distributors worldwide. www.ossur.com



Abonner